The event organisers anticipate that they will receive sponsorship from pharmaceutical companies for this event. As soon as sponsorship is confirmed, the details will be added to this page, their website and all promotional materials where appropriate.
Registrations are now open for the highly anticipated Joint British Diabetes Societies for Inpatient Care (JBDS-IP) Conference 2026, set to take place on Friday 3 July 2026 at The Grand Hotel Leicester.
There were three posters from the ABCD audit programme presented at the Diabetes UK annual professional conference at SEC, Glasgow, 26-28 February 2025.
In a poster from the Worldwide Audit of Testosterone Deficiency in Men with Type 2 Diabetes, Prof Hugh Jones showed that testosterone replacement therapy (TRT) improved symptoms and quality of life increasingly over at least 24 months. TRT also reduced HbA1c increasingly over a three year follow up period.
Join us for this valuable face to face conference as we focus on all things inpatient diabetes, taking place on 13th June in Liverpool.
Hear from our expert speakers who will provide in-depth insight and inform participants about the latest developments in how to introduce the latest innovations in inpatient diabetes care.
By attending the conference, you will:
Do you have any experience of patients with type 1 diabetes who are on Afrezza (inhaled insulin) long-term?
ABCD has been contacted by Professor Colin Dayan who would be interested to know how well it is tolerated. Please contact Prof Dayan directly on dayancm@cardiff.ac.uk to share any insights or experience you may have.
